Tor Henrik A. T.
- Country
- Norway
- Department
- Hematology
Research Overview
- Evaluation of CC-95251 Monotherapy and in Combination with Antineoplastic Agents in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Phase II Multicenter Study on Azacitidine for Minimal Residual Disease Management Post-Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome
Data & Insights
Has run more than one trial at 5 of 23 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating blood-related cancers, with particular emphasis on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS). Their research explores innovative therapeutic approaches for these challenging hematologic conditions.
- Acute Myeloid Leukemia Management
- Myelodysplastic Syndromes Treatment
- Combination Therapy Approaches
The investigator's work includes evaluation of novel therapeutic agents and their potential synergistic effects when combined with existing anti-cancer treatments.
Disease Monitoring
A key focus area includes the monitoring and management of minimal residual disease (MRD) in hematologic disorders. The investigator's work aims to improve patient outcomes through early intervention strategies.
- MRD Detection and Monitoring
- Relapse Prevention Strategies
- Treatment Response Assessment
Their research encompasses the development of protocols for preventing disease progression and improving survival rates in patients with residual disease.
Treatment Innovation
The investigator's research portfolio includes studies of novel therapeutic agents for hematologic malignancies. Their work involves evaluating new treatment approaches and investigating drug efficacy.
- Novel Drug Development
- Treatment Protocol Optimization
- Clinical Outcomes Assessment
The research focuses on developing and validating new therapeutic strategies for patients with blood disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.